Cargando…
Pembrolizumab-Induced Diabetic Ketoacidosis: A Review of Critical Care Case
Diabetic ketoacidosis (DKA) is a commonly encountered diagnosis in the general inpatient and intensive care unit settings. We report a rare case of pembrolizumab-induced DKA in a patient with bladder carcinoma in situ with no prior diagnosis of diabetes. Our case highlights the importance of underst...
Autores principales: | Sankar, Keerthana, Macfarlane, Matthew, Cooper, Odelia, Falk, Jeremy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607337/ https://www.ncbi.nlm.nih.gov/pubmed/34820238 http://dx.doi.org/10.7759/cureus.18983 |
Ejemplares similares
-
A Case of Pembrolizumab-Induced Diabetic Ketoacidosis and Hyperthyroidism in a Patient With Recurrent Esophageal Adenocarcinoma
por: Salangsang, Jonathan, et al.
Publicado: (2023) -
Diabetic Ketoacidosis Secondary to New Onset Type 1 Diabetes Mellitus Related to Pembrolizumab Therapy
por: Hernandez, Andrea, et al.
Publicado: (2021) -
Alpelisib-Induced Diabetic Ketoacidosis
por: Nguyen, Paul, et al.
Publicado: (2021) -
ODP159 A Rare Case of Pembrolizumab Induced Diabetic Ketoacidosis
por: Durrani, Jawahar, et al.
Publicado: (2022) -
New-Onset Autoimmune Diabetes Mellitus Presenting As Diabetic Ketoacidosis in Association With Pembrolizumab Therapy and Long Term Follow-Up: Case Report
por: Pachpande, Vrushali, et al.
Publicado: (2022)